A comparative study on oxidative and antioxidative markers of serum and follicular fluid in GnRH agonist and antagonist cycles

被引:20
|
作者
Celik, Ebru [1 ]
Celik, Onder [1 ]
Kumbak, Banu [2 ]
Yilmaz, Ercan [1 ]
Turkcuoglu, Ilgin [1 ]
Simsek, Yavuz [1 ]
Karaer, Abdullah [1 ]
Minareci, Yagmur [3 ]
Ozerol, Elif [4 ]
Tanbek, Kevser [4 ]
机构
[1] Inonu Univ, Sch Med, Dept Obstet & Gynecol, TR-44280 Malatya, Turkey
[2] Firat Univ, Sch Med, Dept Obstet & Gynecol, TR-23169 Elazig, Turkey
[3] Medi Guven Hosp, Dept Obstet & Gynecol, Manisa, Turkey
[4] Inonu Univ, Sch Med, Dept Biochem, TR-44280 Malatya, Turkey
关键词
Oxidative stress; GnRH antagonist; GnRH agonist; IVF/ICSI; GONADOTROPIN-RELEASING-HORMONE; IN-VITRO FERTILIZATION; NITRIC-OXIDE; OVARIAN STIMULATION; SUPEROXIDE-DISMUTASE; GLUTATHIONE-PEROXIDASE; RANDOMIZED-TRIAL; POOR RESPONDERS; STRESS; PROTOCOL;
D O I
10.1007/s10815-012-9843-6
中图分类号
Q3 [遗传学];
学科分类号
071007 ; 090102 ;
摘要
To determine whether concentrations of oxidative stress markers of follicular fluid and serum are different in GnRH agonist protocol from GnRH antagonist protocol. This was a cross-sectional study. Eighty-four women undergoing controlled ovarian stimulation with either GnRH agonist (n = 39) or GnRH antagonist protocols (n = 45) for IVF/ICSI treatment were assigned by a physician. Blood was obtained at the time of oocyte retrieval, and follicular fluid (FF) from the mature follicles of each ovary was centrifuged and frozen until analysis. Malondialdehyde (MDA), nitric oxide (NO), protein carbonyl (PC), hydroxyl proline (OH-P), sodium oxide dismutase (SOD), reduced glutathione (GSH), glutathione peroxidase (GSH-Px), adenosine deaminase (ADA) and xanthine oxidase (XO) were assessed in the serum and follicular fluid of each participants. The mean serum concentrations of GSH-Px, GSH and MDA were lower in the GnRH antagonist group compared to GnRH agonist group, but mean serum SOD was higher in the GnRH antagonist group. The mean follicular SOD, ADA and NO were higher in GnRH antagonist group than GnRH agonist group. The IVF/ICSI outcomes were similar in both groups. GnRH antagonist protocol is associated with increased oxidative stress. The relation of GnRH analogues with oxidative stress and its implication in follicular growth needs to be addressed in further studies.
引用
收藏
页码:1175 / 1183
页数:9
相关论文
共 50 条
  • [21] Oocyte yield of GnRH antagonist cycles scheduled with a short course of estradiol in the early follicular phase
    Turkgeldi, Engin
    Yildiz, Sule
    Angun, Berk
    Urman, Bulent
    Ata, Baris
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2021, 48 (02) : 278 - 282
  • [22] The effect of coasting on the outcome of intracytoplasmic sperm injection: comparable analysis of GnRH agonist and antagonist cycles
    Karacan, M.
    Usta, A.
    Arvas, A.
    Erdem, E.
    Ulug, M.
    Cebi, Z.
    Camlibel, T.
    CLINICAL AND EXPERIMENTAL OBSTETRICS & GYNECOLOGY, 2018, 45 (01) : 48 - 52
  • [23] GnRH antagonist versus follicular-phase single-dose GnRH agonist protocol in patients of normal ovarian responses during controlled ovarian stimulation
    Geng, Yudi
    Xun, Yang
    Hu, Shiqiao
    Lai, Qiaohong
    Jin, Lei
    GYNECOLOGICAL ENDOCRINOLOGY, 2019, 35 (04) : 309 - 313
  • [24] GnRH agonist versus GnRH antagonist in IVF/ICSI cycles with recombinant LH supplementation: DNA fragmentation and apoptosis in granulosa cells
    Lavorato, Heloisa L.
    Oliveira, Joao Batista A.
    Petersen, Claudia G.
    Vagnini, Laura
    Mauri, Ana L.
    Cavagna, Mario
    Baruffi, Ricardo L. R.
    Franco, Jose G., Jr.
    EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY, 2012, 165 (01) : 61 - 65
  • [25] Analysis of follicular fluid and serum markers of oxidative stress in women with infertility related to endometriosis
    Prieto, Laura
    Quesada, Juan F.
    Cambero, Olivia
    Pacheco, Alberto
    Pellicer, Antonio
    Codoceo, Rosa
    Garcia-Velasco, Juan A.
    FERTILITY AND STERILITY, 2012, 98 (01) : 126 - 130
  • [26] Intensified ovarian stimulation in a GnRH antagonist protocol with agonist triggering: a prospective, clinical feasibility study
    Griesinger, Georg
    Berndt, Henriette
    Schultz, Laura
    Schultze-Mosgau, Askan
    Diedrich, Klaus
    von Otte, Soeren
    REPRODUCTIVE BIOMEDICINE ONLINE, 2011, 22 (02) : 133 - 139
  • [27] GnRH agonist plus vaginal progesterone for luteal phase support in ICSI cycles: a randomized study
    Aboulghar, Mohamed A.
    Marie, Heba
    Amin, Yahia M.
    Aboulghar, Mona M.
    Nasr, Ahmed
    Serour, Gamal I.
    Mansour, Ragaa T.
    REPRODUCTIVE BIOMEDICINE ONLINE, 2015, 30 (01) : 52 - 56
  • [28] Microdose GnRH Agonist Flare-Up versus Ultrashort GnRH Agonist Combined with Fixed GnRH Antagonist in Poor Responders of Assisted Reproductive Techniques Cycles
    Eftekhar, Maryam
    Mohammadian, Farnaz
    Yousefnejad, Fariba
    Khani, Parisa
    INTERNATIONAL JOURNAL OF FERTILITY & STERILITY, 2013, 6 (04) : 266 - 271
  • [29] GnRH-agonist versus GnRH-antagonist IVF cycles: is the reproductive outcome affected by the incidence of progesterone elevation on the day of HCG triggering? A randomized prospective study
    Papanikolaou, E. G.
    Pados, G.
    Grimbizis, G.
    Bili, E.
    Kyriazi, L.
    Polyzos, N. P.
    Humaidan, P.
    Tournaye, H.
    Tarlatzis, B.
    HUMAN REPRODUCTION, 2012, 27 (06) : 1822 - 1828
  • [30] Follicular fluid and serum vascular endothelial growth factor, interleukin (IL)-1β and glycodelin concentrations: comparison between long-gonadotropin-releasing hormone (GnRH)-agonist and GnRH-antagonist cycles: a randomized controlled trial
    Aydin, Yunus
    Hassa, Hikmet
    Isikci, Tugba
    Colak, Omer
    GYNECOLOGICAL ENDOCRINOLOGY, 2014, 30 (10) : 734 - 738